These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9849440)

  • 41. Molecular pathology and potential therapeutic targets in soft-tissue sarcoma.
    Todd R; Lunec J
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):939-48. PubMed ID: 18533803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemotherapy of advanced sarcomas of bone and soft tissue.
    Antman KH
    Semin Oncol; 1992 Dec; 19(6 Suppl 12):13-20. PubMed ID: 1485169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sarcoma chemotherapy.
    Walczak BE; Irwin RB
    J Am Acad Orthop Surg; 2013 Aug; 21(8):480-91. PubMed ID: 23908254
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemotherapy of patients with advanced soft tissue sarcoma with use of DVA (vindesine sulfate), adriamycin and cyclophosphamide (DAC).
    Brenner J; Magill GB; Wissel P; Sordillo PP
    Cancer; 1983 Oct; 52(7):1142-5. PubMed ID: 6349786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vorinostat in refractory soft tissue sarcomas - Results of a multi-centre phase II trial of the German Soft Tissue Sarcoma and Bone Tumour Working Group (AIO).
    Schmitt T; Mayer-Steinacker R; Mayer F; Grünwald V; Schütte J; Hartmann JT; Kasper B; Hüsing J; Hajda J; Ottawa G; Mechtersheimer G; Mikus G; Burhenne J; Lehmann L; Heilig CE; Ho AD; Egerer G
    Eur J Cancer; 2016 Sep; 64():74-82. PubMed ID: 27367154
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New chemotherapeutic strategies for soft tissue sarcomas.
    Patel SR; Benjamin RS
    Semin Surg Oncol; 1999; 17(1):47-51. PubMed ID: 10402637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pre- and perioperative perfusion chemotherapy for soft tissue sarcoma of the limbs.
    Meyer M; Muchmore JH; Krementz ET
    Cancer Treat Res; 1991; 56():105-26. PubMed ID: 1681873
    [No Abstract]   [Full Text] [Related]  

  • 48. The use of hematological growth factors to enable dose intensification in chemotherapy for soft tissue sarcomas.
    Liem GS; Verweij J
    Stem Cells; 1994 Jul; 12(4):402-8. PubMed ID: 7951007
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emerging therapies for sarcoma.
    Movva S
    Curr Probl Cancer; 2013; 37(2):87-101. PubMed ID: 23719333
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemotherapy of advanced soft tissue and osteosarcomas.
    Kane MJ
    Semin Oncol; 1989 Aug; 16(4):297-304. PubMed ID: 2667144
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of adult soft tissue sarcoma: old concepts, new insights, and potential for drug discovery.
    Aragon-Ching JB; Maki RG
    Cancer Invest; 2012 May; 30(4):300-8. PubMed ID: 22480231
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Chemotherapy of advanced bone and soft tissue sarcoma].
    Yamawaki S; Isu K; Ubayama Y; Yamaguti H; Gotou M
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1757-63. PubMed ID: 6541020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical trails referral resource. Clinical trials in soft tissue sarcomas.
    Saxman S; Schoenfeldt M
    Oncology (Williston Park); 2002 Oct; 16(10):1359-60. PubMed ID: 12435205
    [No Abstract]   [Full Text] [Related]  

  • 54. Phase II study of liposomal muramyl tripeptide phosphatidylethanolamine (MTP/PE) in advanced soft tissue sarcomas of the adult. An EORTC Soft Tissue and Bone Sarcoma Group study.
    Verweij J; Judson I; Steward W; Coleman R; Woll P; van Pottelsberghe C; van Glabbeke M; Mouridsen H
    Eur J Cancer; 1994; 30A(6):842-3. PubMed ID: 7917546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Drug therapy for soft tissue sarcoma].
    Zhang X
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(37):2889-2892. PubMed ID: 31607015
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phase II study of mitozolomide in advanced soft tissue sarcoma of adults: the EORTC Soft Tissue and Bone Sarcoma Group.
    Somers R; Santoro A; Verweij J; Lucas P; Rouëssé J; Kok T; Casali A; Seynaeve C; Thomas D
    Eur J Cancer; 1992; 28A(4-5):855-7. PubMed ID: 1524907
    [No Abstract]   [Full Text] [Related]  

  • 57. The EORTC soft tissue and bone sarcoma group. European Organisation for Research and Treatment of Cancer.
    Donato Di Paola E; Nielsen OS;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S138-41. PubMed ID: 11858980
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The pharmacologic basis of ifosfamide use in adult patients with advanced soft tissue sarcomas.
    Tascilar M; Loos WJ; Seynaeve C; Verweij J; Sleijfer S
    Oncologist; 2007 Nov; 12(11):1351-60. PubMed ID: 18055856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phase I clinical study of carminomycin: its activity against soft tissue sarcomas.
    Perevodchikova NI; Lichinitser MR; Gorbunova VA
    Cancer Treat Rep; 1977 Dec; 61(9):1705-7. PubMed ID: 340034
    [No Abstract]   [Full Text] [Related]  

  • 60. Sarcoma.
    Scurr M; Judson I
    Cancer Chemother Biol Response Modif; 2003; 21():637-53. PubMed ID: 15338767
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.